[1] |
TAN Yong, LIU Hui, WU Li-ming, LIU Wen-ying, OU-YANG Zai-xing, HU Le-sheng, SONG Hao, HUANG Cong-yun, WU Qing-song.
The relationship between preoperative serum hepatitis B virus DNA load and postoperative liver function in patients with hepatocellular carcinoma resection
[J]. Lingnan Modern Clinics In Surgery, 2024, 24(04): 209-214.
|
[2] |
ZHENG Biao, CHEN Xu, QIAN Junlin, XU Baoshi, ZHEN Chaohui, LIANG Rui.
Expression of RAD54B in liver hepatocellular carcinoma and its influence on clinical prognosis
[J]. Lingnan Modern Clinics In Surgery, 2024, 24(04): 225-230.
|
[3] |
PENG Lin-hui, CHEN Tao, XU Yun-xiu-xiu, WANG Jie, CHEN Jie, LI Yong, HUANG Pin-bo, ZHONG Guo-ping, CHEN Qian, YE Cong-ting, CHEN Ya-jin.
mFOLFOX7 venous chemotherapy plus camrelizumab and apatinib for hepatocellular carcinoma in CNLC stage Ⅲ (VIC-TRIPLET): a prospective study
[J]. Lingnan Modern Clinics In Surgery, 2024, 24(01): 1-6.
|
[4] |
LUO Wan-rong, ZHANG Wen-yue, LUO Bao-ming.
Construction and validation of a prognostic risk model for hepatocellular carcinoma based on angiogenesis-related lncRNAs
[J]. Lingnan Modern Clinics In Surgery, 2024, 24(01): 7-13.
|
[5] |
LIN Kun-peng, BA Ming-chen, TANG Yun-qiang, WANG Jia-kang, LIN Xiao-chun.
Correlation analysis of FAM72 gene family in prognosis and immune infiltration of hepatocellular carcinoma
[J]. Lingnan Modern Clinics In Surgery, 2024, 24(01): 14-25.
|
[6] |
HUANG Zhi-feng, JIAO Yuan-jun, XU Zhe, LIU Ji-kui, HUANG Dong, OU Xi, LIU Xiao-ping.
FOXP3 promotes cell migration via EMT in hepatocellular cancer
[J]. Lingnan Modern Clinics In Surgery, 2023, 23(06): 449-454.
|
[7] |
Guangdong Province Precision Medicine Association Hematology Branch Hemostasis Youth Committee, Expert Consensus Writing Group on the Diagnosis, Treatment of Thrombophilia in Guangdong Province.
Expert consensus on the diagnosis and treatment of thrombophilia in Guangdong Province
[J]. Lingnan Modern Clinics In Surgery, 2023, 23(05): 367-378.
|
[8] |
FENG Ming-bin, LIU Tai, CHEN Ke-ying, TANG Qi-bin.
Metastatic cervical carcinoma to the gallbladder: a case report
[J]. Lingnan Modern Clinics In Surgery, 2023, 23(05): 424-426.
|
[9] |
HUANG Gui-zhong, LIN Qiao-hong, YIN Peng-fei, ZHANG Jian-long.
Constructing and validating an online predictive model of severe postoperative complication for hepatocellular carcinoma
[J]. Lingnan Modern Clinics In Surgery, 2023, 23(04): 289-293.
|
[10] |
LUO Xuan, LONG Yin, HUANG Zi-qi, HE Xiao-dong, HUANG Jue, LIAO Jian-guo, ZHANG Lei.
Real-world analysis of mFOLFOX systemic chemotherapy combined with immunotherapy and targeted therapy for unresectable hepatocellular carcinoma
[J]. Lingnan Modern Clinics In Surgery, 2023, 23(04): 294-301.
|
[11] |
QIAN Jun-lin, TANG Hong-tao, LIN Wei, HU Ze-min.
Research progress of hepatic arterial infusion chemotherapy with FOLFOX regimen
[J]. Lingnan Modern Clinics In Surgery, 2023, 23(04): 347-352.
|
[12] |
HUANG Rui-qin, HE Kun, QIAN Jun-lin, LUO Qi-jie.
Analysis of risk factors affecting the postoperative prognosis of patients with hepatocellular carcinoma:a single-center analysis
[J]. Lingnan Modern Clinics In Surgery, 2023, 23(03): 205-214.
|
[13] |
WU Wei-zi, ZHANG Guan-lan, TANG Yu-xing, ZHENG Qing, CHEN Yu, CHEN Ji-tian, ZHAN Yan-ting, MO Wei-jia.
Clinical value of up-regulated expression of ANAPC5 mRNA in hepatocellular carinnoma and analysis of related pathways
[J]. Lingnan Modern Clinics In Surgery, 2023, 23(03): 230-237.
|
[14] |
LIU Li-qing, ZHANG Li, JIN Yan, XU Jing.
Research progress on risk factors of postoperative recurrence of liver cancer
[J]. Lingnan Modern Clinics In Surgery, 2023, 23(03): 269-276.
|
[15] |
CHEN Xi, CHEN Jie, CHEN Tao, CHEN Ya-jin.
Interpreting the updates of the 2023 Version 1 NCCN hepatocellular carcinoma clinical practice guidelines
[J]. Lingnan Modern Clinics In Surgery, 2023, 23(02): 95-99.
|